{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:43:01Z","timestamp":1785300181271,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1053\/j.ajkd.2011.11.030","type":"journal-article","created":{"date-parts":[[2012,1,5]],"date-time":"2012-01-05T20:50:16Z","timestamp":1325796616000},"page":"810-818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":164,"title":["Regional Citrate Versus Heparin Anticoagulation for Continuous Renal Replacement Therapy: A Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1053","volume":"59","author":[{"given":"Mei-Yi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Ho","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyi-Huey","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuh-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hsiung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Wai","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.ajkd.2011.11.030_bib1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ncpneph0423","article-title":"Continuous dialysis is superior to intermittent dialysis in acute kidney injury of the critically ill patient","volume":"3","author":"Ronco","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2011.11.030_bib2","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1097\/00003246-199910000-00026","article-title":"A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration","volume":"27","author":"Reeves","year":"1999","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1053\/j.ajkd.2011.11.030_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000083938","article-title":"Filter run time in CVVH: pre- versus post-dilution and nadroparin versus regional heparin-protamine anticoagulation","volume":"23","author":"van der Voort","year":"2005","journal-title":"Blood Purif"},{"issue":"4","key":"10.1053\/j.ajkd.2011.11.030_bib4","first-page":"566","article-title":"Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding","volume":"16","author":"Morabito","year":"2003","journal-title":"J Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2011.11.030_bib5","first-page":"527","article-title":"Regional filter heparinization for continuous veno-venous hemofiltration in liver transplant recipients","volume":"69","author":"Biancofiore","year":"2003","journal-title":"Minerva Anestesiol"},{"key":"10.1053\/j.ajkd.2011.11.030_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000424629","article-title":"Influence of coagulation parameters on filter running time during continuous venovenous hemofiltration","volume":"116","author":"Stefanidis","year":"1995","journal-title":"Contrib Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2011.11.030_bib7","first-page":"659","article-title":"The heparin-protamine interaction","volume":"40","author":"Carr","year":"1999","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"9","key":"10.1053\/j.ajkd.2011.11.030_bib8","first-page":"1768","article-title":"Heparin-induced thrombocytopenia during continuous haemofiltration","volume":"10","author":"Samuelsson","year":"1995","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2011.11.030_bib9","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ki.1990.300","article-title":"Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients","volume":"38","author":"Mehta","year":"1990","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2011.11.030_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000245646","article-title":"Citrate anticoagulation for continuous renal replacement therapy in the critically ill","volume":"29","author":"Oudemans-van Straaten","year":"2010","journal-title":"Blood Purif"},{"issue":"2","key":"10.1053\/j.ajkd.2011.11.030_bib11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00134-005-0044-y","article-title":"Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?","volume":"32","author":"Oudemans-van Straaten","year":"2006","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1053\/j.ajkd.2011.11.030_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3904\/kjim.2011.26.1.68","article-title":"Regional anticoagulation with citrate is superior to systemic anticoagulation with heparin in critically ill patients undergoing continuous venovenous hemodiafiltration","volume":"26","author":"Park","year":"2011","journal-title":"Korean J Intern Med"},{"issue":"6","key":"10.1053\/j.ajkd.2011.11.030_bib13","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/j.1523-1755.2005.00342.x","article-title":"Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients","volume":"67","author":"Kutsogiannis","year":"2005","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2011.11.030_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00134-003-2047-x","article-title":"Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study","volume":"30","author":"Monchi","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.ajkd.2011.11.030_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"issue":"10","key":"10.1053\/j.ajkd.2011.11.030_bib16","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"10.1053\/j.ajkd.2011.11.030_bib17","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1046\/j.1365-2168.2000.01610.x","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement","volume":"87","author":"Moher","year":"2000","journal-title":"Br J Surg"},{"key":"10.1053\/j.ajkd.2011.11.030_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"10.1053\/j.ajkd.2011.11.030_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"1","key":"10.1053\/j.ajkd.2011.11.030_bib20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/ndt\/gfq575","article-title":"Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial","volume":"26","author":"Hetzel","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2011.11.030_bib21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/CCM.0b013e3181953c5e","article-title":"Citrate anticoagulation for continuous venovenous hemofiltration","volume":"37","author":"Oudemans-van Straaten","year":"2009","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1053\/j.ajkd.2011.11.030_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/039139880703000404","article-title":"A pilot randomized controlled crossover study comparing regional heparinization to regional citrate anticoagulation for continuous venovenous hemofiltration","volume":"30","author":"Fealy","year":"2007","journal-title":"Int J Artif Organs"},{"issue":"5","key":"10.1053\/j.ajkd.2011.11.030_bib23","first-page":"602","article-title":"Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding","volume":"20","author":"Betjes","year":"2007","journal-title":"J Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2011.11.030_bib24","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00134-002-1443-y","article-title":"Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge","volume":"28","author":"Gabutti","year":"2002","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1053\/j.ajkd.2011.11.030_bib25","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0272-6386(12)80675-5","article-title":"Anticoagulation in patients treated by continuous venovenous hemofiltration: a retrospective study","volume":"24","author":"Martin","year":"1994","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2011.11.030_bib26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1592\/phco.23.6.745.32188","article-title":"Frequency of heparin-induced thrombocytopenia in critical care patients","volume":"23","author":"Verma","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1053\/j.ajkd.2011.11.030_bib27","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.5858\/2002-126-1415-PCMALT","article-title":"Platelet count monitoring and laboratory testing for heparin-induced thrombocytopenia","volume":"126","author":"Warkentin","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.ajkd.2011.11.030_bib28","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/748320","article-title":"Citrate anticoagulation for continuous renal replacement therapy in critically ill patients: success and limits","volume":"2011","author":"Mariano","year":"2011","journal-title":"Int J Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2011.11.030_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1525-139X.2008.00545.x","article-title":"Anticoagulation for continuous renal replacement therapy","volume":"22","author":"Tolwani","year":"2009","journal-title":"Semin Dial"},{"issue":"5","key":"10.1053\/j.ajkd.2011.11.030_bib30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1056\/NEJM198302033080506","article-title":"Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding","volume":"308","author":"Pinnick","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2011.11.030_bib31","doi-asserted-by":"crossref","unstructured":"Balogun RA, Turgut F, Caldwell S, Abdel-Rahman EM. Regional citrate anticoagulation in critically ill patients with liver and kidney failure [published online ahead of print May 23, 2011]. J Nephrol. doi:10.5301\/JN.2011.8363.","DOI":"10.5301\/JN.2011.8363"},{"issue":"2","key":"10.1053\/j.ajkd.2011.11.030_bib32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/CCM.0b013e318205c500","article-title":"Regional anticoagulation with citrate: expanding its indications","volume":"39","author":"Morgera","year":"2011","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1053\/j.ajkd.2011.11.030_bib33","doi-asserted-by":"crossref","first-page":"c131","DOI":"10.1159\/000079171","article-title":"Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience","volume":"97","author":"Morgera","year":"2004","journal-title":"Nephron Clin Pract"},{"issue":"9","key":"10.1053\/j.ajkd.2011.11.030_bib34","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s00134-007-0719-7","article-title":"Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study","volume":"33","author":"Joannidis","year":"2007","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1053\/j.ajkd.2011.11.030_bib35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00003246-200002000-00022","article-title":"Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: a double-blind, randomized, crossover study","volume":"28","author":"de Pont","year":"2000","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1053\/j.ajkd.2011.11.030_bib36","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1525-1594.1993.tb00620.x","article-title":"Anticoagulation with low molecular weight heparin (Fragmin) during continuous hemodialysis in the intensive care unit","volume":"17","author":"Jeffrey","year":"1993","journal-title":"Artif Organs"},{"issue":"2","key":"10.1053\/j.ajkd.2011.11.030_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcrc.2005.01.001","article-title":"Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy?","volume":"20","author":"Bagshaw","year":"2005","journal-title":"J Crit Care"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263861101691X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027263861101691X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:58:05Z","timestamp":1759456685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027263861101691X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S027263861101691X"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2011.11.030","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13931957.15387059","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.13931957.793472876","asserted-by":"object"}]},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regional Citrate Versus Heparin Anticoagulation for Continuous Renal Replacement Therapy: A Meta-Analysis of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2011.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}